GEORGE ANASTASIO: Open Payments
NPI 1770508087 · SUFFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,981 in 149 payments from 30 companies in 2025. Trend: 2023 $2,700 · 2024 $2,821 · 2025 $2,981
Food & beverage: $2,981
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $426 |
| AstraZeneca Pharmaceuticals LP | 21 | $410 |
| Novo Nordisk Inc | 10 | $194 |
| Amgen Inc. | 8 | $185 |
| Axsome Therapeutics, Inc. | 4 | $131 |
| Amneal Pharmaceuticals LLC | 6 | $129 |
| Abbott Laboratories | 6 | $119 |
| GlaxoSmithKline, LLC. | 5 | $110 |
| Exact Sciences Corporation | 5 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $96 |
Products named: AIRSUPRA, VRAYLAR, UBRELVY, EVENITY, Auvelity, UNITHROID, TRELEGY ELLIPTA, FREESTYLE LIBRE 3.
Industry payments across CT — which companies pay providers there.
